共 50 条
- [31] DIFFERENT FIBRINOLYTIC POTENCIES OF 2 FORMS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - NHLBI THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL [J]. CLINICAL RESEARCH, 1986, 34 (02): : A631 - A631
- [32] RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J]. LANCET, 1985, 1 (8433): : 842 - 847
- [33] ARRHYTHMIAS AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J]. BRITISH HEART JOURNAL, 1988, 59 (01): : 136 - 137
- [37] USEFULNESS OF LATE CORONARY THROMBOLYSIS (RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR) IN PRESERVING LEFT-VENTRICULAR FUNCTION IN ACUTE MYOCARDIAL-INFARCTION [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (19): : 1281 - 1286
- [39] COMPARISON OF INVASIVE AND CONSERVATIVE STRATEGIES AFTER TREATMENT WITH INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) PHASE-II TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10): : 618 - 627
- [40] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN THE EARLY PHASE OF ACUTE MYOCARDIAL-INFARCTION [J]. BRITISH HEART JOURNAL, 1987, 57 (06): : 582 - 583